Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Malignant melanoma in situ
ADR ID BADD_A07388
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.03      Skin neoplasms malignant and unspecified
16.03.01      Skin melanomas (excl ocular)
16.03.01.004      Malignant melanoma in situ
23      Skin and subcutaneous tissue disorders
23.08      Skin neoplasms malignant and unspecified
23.08.01      Skin melanomas (excl ocular)
23.08.01.004      Malignant melanoma in situ
Description Not Available
MedDRA Code 10025652
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acral lentiginous melanoma in situ | Malignant melanoma in situ | Melanoma in situ | Superficial spreading melanoma in situ
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin0.005728%
BADD_D00156Apremilast--
BADD_D00195Azathioprine0.001436%
BADD_D00623Dexamethasone0.000687%
BADD_D00680Dimethyl fumarate0.002751%
BADD_D01142Imiquimod0.002317%
BADD_D01253Lenalidomide--
BADD_D01366Medroxyprogesterone acetate0.000511%
BADD_D02018Sildenafil0.011904%
BADD_D02106Tadalafil0.001918%
BADD_D02344Vemurafenib0.003248%
BADD_D02464Fingolimod0.009843%
The 1th Page    1    Total 1 Pages